Leiomyomas of the bladder constitute <0.5% of all bladder tumors, with about 250 cases reported. Most patients present with urinary frequency or obstructive urinary symptoms. There are rare cases with other presentations, such as dyspareunia. We report a 22-year-old female who presented with complaints of pelvic discomfort, dysuria, and dyspareunia. Imaging and cystoscopy showed a protruding bladder lesion, which was excised through a transurethral resection. The pathologic diagnosis was bladder leiomyoma. Although being a benign condition, they can cause several different symptoms and should be early diagnosed and treated.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5532898 | PMC |
| http://dx.doi.org/10.4103/UA.UA_164_16 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A rare case of female urinary retention caused by urethral leiomyoma: A case report.
Int J Surg Case Rep
January 2025
Faculty of Medicine, Universitas Padjadjaran, Bandung, West Java, Indonesia; Urology Department, Hasan Sadikin General Hospital, Bandung, West Java, Indonesia.
Introduction And Importance: Female urethral leiomyoma is a rare benign tumor that originates from the smooth muscle cells in the urethra's wall. Surgical resection is often the primary treatment option. However, the tumor's location and size can present challenges for complete removal while preserving urethral function.
View Article and Find Full Text PDFCase report: Bladder leiomyoma presenting as dysuria.
Radiol Case Rep
January 2025
Department of Radiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Leiomyoma of the bladder is an unusual cause of benign smooth muscle tumor, only reported about 250 times in the literature. Imaging studies including computed tomography (CT) and magnetic resonance imaging (MRI) scans are useful in defining the extent and location of the tumor, however, immunohistology samples must be obtained to rule out similar appearing cancerous masses. In this article, we report the case of a 50-year-old male diagnosed with leiomyoma of the bladder that initially presented as dysuria and raised suspicion of a bladder transitional cell carcinoma (TCC).
View Article and Find Full Text PDFRed urine syndrome in dromedary camels: Clinical, etiological, hematobiochemical sonographic, and pathologic findings.
Open Vet J
September 2024
Department of Medical Biosciences, College of Veterinary Medicine, Qassim University, Buraidah, Saudi Arabia.
Background: Although blood urine is frequently observed in dromedary camels, little attention is gained and only it was reported as case reports.
Aim: This study was carried out to examine dromedary camels suffering from red urine syndrome from the points of clinical, etiological, hematobiochemical, ultrasonographic, and pathological characteristics.
Methods: Thirty-one camels with red urine and fifteen controls were enrolled.
Characteristics and outcomes in bladder Leiomyoma management: a systematic review of case reports and case series from the past 20 years.
BMC Urol
November 2024
Department of Surgery, Division of Urology, School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia.
Introduction: Bladder leiomyomas (LM) are uncommon, non-cancerous growths that originate from the smooth muscle cells of the bladder and constitute 0.5% of bladder tumor cases. This review aims to compile existing data and present a summary of bladder leiomyomas' characteristics, management, and related outcomes.
View Article and Find Full Text PDFEfficacy and safety of different doses of mifepristone in the treatment of uterine fibroids: A meta-analysis.
Eur J Obstet Gynecol Reprod Biol
December 2024
Department of Gynecology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, PR China. Electronic address:
Article Synopsis
- The study aimed to assess the safety and effectiveness of various doses of mifepristone (2.5 mg to 50 mg) in treating uterine fibroids through a systematic review of randomized controlled trials (RCTs).
- A meta-analysis of 18 studies involving 2,066 patients indicated that mifepristone significantly reduced uterine and fibroid volumes and improved symptoms like pelvic pain and urinary issues compared to a control group.
- While mifepristone showed benefits, it also caused some side effects such as increased endometrial thickness and hot flashes, with the 5 mg/day dose for three months being identified as the potentially best regimen for treatment.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!